Pharma Journalist -

Astellas Pharma Inc., through its wholly-owned subsidiary Universal Cells, Inc, and Adaptimmune Therapeutics plc, a leader in cell therapy to treat cancer, announced that they have…
Read More...

MorphoSys AG and Incyte Corporation announced that the companies have entered into a collaboration and license agreement to further develop and commercialize MorphoSys' proprietary…
Read More...

SMi has released an exclusive interview with industry expert Martin Slegl, Regional Principal of East Europe, IQVIA, ahead of the upcoming Parallel Trade conference this February.  …
Read More...

SMi Reports: Industry expert and conference speaker, Robert Young, Principal, Blue Burgundy, was interviewed ahead of March’s AI in Drug Discovery conference. SMi Group’s inaugural…
Read More...

Charles River announced a multi-year drug discovery collaboration with Takeda Pharmaceutical Company Limited. Together, Charles River and Takeda will launch multiple integrated programs…
Read More...

BioMotiv, a mission-driven pharma company part of The Harrington Project for discovery and development, and Atomwise, the leader in using artificial intelligence (AI) for small molecule…
Read More...

Coherus BioSciences, Inc. announced the Company has entered into a licensing agreement with Innovent Biologics, (Suzhou) Co., Ltd. to commercialize Innovent’s biosimilar candidate to…
Read More...

SMi Reports: Pre-Filled Syringes East Coast 2020 will feature 3 exclusive presentations dedicated to digital connectivity in the PFS industry. Building on the success of last year’s…
Read More...

SMi reports: Registration is now open for the Highly Potent Active Pharmaceutical Ingredients Conference, which will convene in London on 11th-12th May 2020. SMi Group are pleased to…
Read More...

Alnylam Pharmaceuticals announced that the Company has initiated a rolling submission of its New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for lumasiran, an…
Read More...